Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation.

Pierrot-Deseilligny C, Rivaud-Péchoux S, Clerson P, de Paz R, Souberbielle JC.

Ther Adv Neurol Disord. 2012 Jul;5(4):187-98. doi: 10.1177/1756285612447090.

2.

Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis.

Simpson S Jr, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H, Dwyer T, Gies P, van der Mei I.

Ann Neurol. 2010 Aug;68(2):193-203. doi: 10.1002/ana.22043.

PMID:
20695012
3.

Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.

Runia TF, Hop WC, de Rijke YB, Buljevac D, Hintzen RQ.

Neurology. 2012 Jul 17;79(3):261-6. doi: 10.1212/WNL.0b013e31825fdec7. Epub 2012 Jun 13.

PMID:
22700811
4.

A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.

Soilu-Hänninen M, Laaksonen M, Laitinen I, Erälinna JP, Lilius EM, Mononen I.

J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):152-7. Epub 2007 Jun 19.

PMID:
17578859
5.

Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.

Mowry EM, Krupp LB, Milazzo M, Chabas D, Strober JB, Belman AL, McDonald JC, Oksenberg JR, Bacchetti P, Waubant E.

Ann Neurol. 2010 May;67(5):618-24. doi: 10.1002/ana.21972.

PMID:
20437559
6.

Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial.

Kampman MT, Steffensen LH, Mellgren SI, Jørgensen L.

Mult Scler. 2012 Aug;18(8):1144-51. doi: 10.1177/1352458511434607. Epub 2012 Feb 21.

PMID:
22354743
7.

Skeletal and hormonal responses to vitamin D supplementation during sunlight deprivation in Antarctic expeditioners.

Iuliano-Burns S, Ayton J, Hillam S, Jones G, King K, Macleod S, Seeman E.

Osteoporos Int. 2012 Oct;23(10):2461-7. doi: 10.1007/s00198-011-1858-9. Epub 2012 Jan 4.

PMID:
22215183
8.
9.

Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.

Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.

Nephrol Dial Transplant. 2008 Nov;23(11):3670-6. doi: 10.1093/ndt/gfn339. Epub 2008 Jun 24.

PMID:
18579534
10.

Sunlight exposure or vitamin D supplementation for vitamin D-deficient non-western immigrants: a randomized clinical trial.

Wicherts IS, Boeke AJ, van der Meer IM, van Schoor NM, Knol DL, Lips P.

Osteoporos Int. 2011 Mar;22(3):873-82. doi: 10.1007/s00198-010-1343-x. Epub 2010 Aug 4.

11.

Immunomodulatory effects of Vitamin D in multiple sclerosis.

Correale J, Ysrraelit MC, Gaitán MI.

Brain. 2009 May;132(Pt 5):1146-60. doi: 10.1093/brain/awp033. Epub 2009 Mar 24.

PMID:
19321461
12.

High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency.

von Restorff C, Bischoff-Ferrari HA, Theiler R.

Bone. 2009 Oct;45(4):747-9. doi: 10.1016/j.bone.2009.06.012. Epub 2009 Jun 17.

PMID:
19539796
13.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
14.

Self-prescribed high-dose vitamin D3: effects on biochemical parameters in two men.

Kimball S, Vieth R.

Ann Clin Biochem. 2008 Jan;45(Pt 1):106-10. doi: 10.1258/acb.2007.007074.

PMID:
18275686
15.

Safety of vitamin D3 in adults with multiple sclerosis.

Kimball SM, Ursell MR, O'Connor P, Vieth R.

Am J Clin Nutr. 2007 Sep;86(3):645-51.

16.

Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.

Hiremath GS, Cettomai D, Baynes M, Ratchford JN, Newsome S, Harrison D, Kerr D, Greenberg BM, Calabresi PA.

Mult Scler. 2009 Jun;15(6):735-40. doi: 10.1177/1352458509102844. Epub 2009 Apr 21.

PMID:
19383644
17.
18.

Vitamin D status in a rural postmenopausal female population.

Lappe JM, Davies KM, Travers-Gustafson D, Heaney RP.

J Am Coll Nutr. 2006 Oct;25(5):395-402.

PMID:
17031008
19.

The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis.

Golan D, Staun-Ram E, Glass-Marmor L, Lavi I, Rozenberg O, Dishon S, Barak M, Ish-Shalom S, Miller A.

Brain Behav Immun. 2013 Aug;32:180-5. doi: 10.1016/j.bbi.2013.04.010. Epub 2013 May 7.

PMID:
23665342
20.

Calcium and vitamin D supplementation after gastric bypass should be individualized to improve or avoid hyperparathyroidism.

Flores L, Osaba MJ, Andreu A, Moizé V, Rodríguez L, Vidal J.

Obes Surg. 2010 Jun;20(6):738-43. doi: 10.1007/s11695-010-0138-7.

PMID:
20369304

Supplemental Content

Support Center